Of Guinea pigs and gratitude: The difficult discourse of clinical trials from the cancer patient perspective

European Journal of Cancer Care

Volumn 22, Issue 5, 2013, Pages 663-672

  Thorne, Sally ^a   Taylor, K ^a   Stephens, J M L ^a   Kim Sing, C ^b   Hislop, T G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cancer journey; Clinical trial; Communication; Interpretive description; Patient centred care; Psychosocial oncology

Indexed keywords

ADULT; AGED; ARTICLE; ASSOCIATION; CANCER JOURNEY; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; INTERPRETIVE DESCRIPTION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT-CENTRED CARE; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL ONCOLOGY;

CANCER JOURNEY; CLINICAL TRIAL; COMMUNICATION; INTERPRETIVE DESCRIPTION; PATIENT-CENTRED CARE; PSYCHOSOCIAL ONCOLOGY;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; COMMUNICATION; CUES; DECISION MAKING; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASMS; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT-CENTERED CARE; PHYSICIAN-PATIENT RELATIONS;

EID: 84882258622     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12075     Document Type: Article

References (57)

1. Albrecht T.L., Ruckdeschel J.C., Riddle D.L., Blanchard C.G., Penner L.A., Coovert M.D. & Quinn G. (2003) Communication and consumer decision making about cancer clinical trials. Patient Education and Counseling 50, 39-42.
2. Albrecht T.L., Franks M.M. & Ruckdeschel J.C. (2005) Communication and informed consent. Current Opinion in Oncology 17, 336-339.
3. American Cancer Society (2012) Cancer Facts and Figures. American Cancer Society, Atlanta, GA, USA.
4. Antoniou S.A., Antoniou G.A., Granderath F.A., Mavroforou A., Giannoukas A.D. & Antoniou A.I. (2010) Reflections of the Hippocratic Oath in modern medicine. [Historical Article] World Journal of Surgery 34, 3075-3079.
5. Appelbaum P.S., Roth L.H. & Lidz C. (1982) The therapeutic misconception: informed consent in psychiatric research. International Journal of Law and Psychiatry 5, 319-329.
6. Barton E. & Eggly S. (2009) Ethical or unethical persuasion? the rhetoric of offers to participate in clinical trials. Written Communication 26, 295-319.
7. Biedrzycki B.A. (2010) Decision making for cancer clinical trial participation: a systematic review. Oncology Nursing Forum 37, E387-E399.
8. Brown R.F., Butow P.N., Butt D.G., Moore A.R. & Tattersall M.H. (2004) Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Social Science and Medicine 58, 379-390.
9. Brown R., Bylund C.L., Siminoff L.A. & Slovin S.F. (2011a) Seeking informed consent to Phase I cancer clinical trials: identifying oncologists' communication strategies. Psycho-Oncology 20, 361-368.
10. Brown R.F., Shuk E., Leighl N., Butow P., Ostroff J., Edgerson S. & Tattersall M. (2011b) Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Supportive Care in Cancer 19, 1227-1238.
11. Canadian Cancer Research Alliance (2011) Report on the State of Cancer Clinical Trials in Canada. Toronto.
12. Chalmers T.C., Smith H., Jr., Blackburn B., Silverman B., Schroeder B., Reitman D. & Ambroz A. (1981) A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 2, 31-49.
13. Coyne C.A., Xu R., Raich P., Plomer K., Dignan M., Wenzel L.B., Fairclough D., Habermann T., Schnell L., Quella S., Cella D., Eastern Cooperative Oncology Group (2003) Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 21, 836-842.
14. Curran W.J., Jr, Schiller J.H., Wolkin A.C. & Comis R.L. (2008) Addressing the current challenges of non-small-cell lung cancer clinical trial accrual. Clinical Lung Cancer 9, 222-226.
15. Daugherty C., Ratain M.J., Grochowski E., Stocking C., Kodish E., Mick R. & Siegler M. (1995) Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology 13, 1062-1072.
16. Davison B.J., So A., Goldenberg S.L., Berkowitz J. & Gleave M.E. (2008) Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective. BJU International 101, 982-987.
17. Edwards M.J. (1998) Access to quality cancer care: consensus statement of the American Federation of Clinical Oncologic Societies. Annals of Surgical Oncology 5, 657-659.
18. Ehrenberger H.E., Breeden J.R. & Donovan M.E. (2003) A demonstration project to increase the awareness of cancer clinical trials among community-dwelling seniors. Oncology Nursing Forum 30, E80-E83.
19. Epstein R.M. & Street R.L. (2007) Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. Bethesda, MD, USA. NIH Publication No. 07-6225.
20. Fallowfield L. & Jenkins V. (1999) Effective communication skills are the key to good cancer care. European Journal of Cancer 35, 1592-1597.
21. Feldman-Stewart D., Brundage M.D., Tishelman C. & SCRN Communication Team (2005) A conceptual framework for patient-professional communication: an application to the cancer context. Psycho-Oncology 14, 801-809.
22. Ford J.G., Howerton M.W., Lai G.Y., Gary T.L., Bolen S., Gibbons M.C., Tilburt J., Baffi C., Tanpitukpongse T.P., Wilson R.F., Powe N.R., Bass E.B. (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112, 228-242.
23. Gilger E.A., Groben V.J. & Hinds P.S. (2002) Osteosarcoma nursing care guidelines: a tool to enhance the nursing care of children and adolescents enrolled on a medical research protocol. Journal of Pediatric Oncology Nursing 19, 172-181.
24. Grant C.H., Cissna K.N. & Rosenfeld L.B. (2000) Patients' perceptions of physicians communication and outcomes of the accrual to trial process. Health Communication 12, 23-39.
25. Grossman S.A., Piantadosi S. & Covahey C. (1994) Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? Journal of Clinical Oncology 12, 2211-2215.
26. Gysels M., Richardson A. & Higginson I.J. (2005) Communication training for health professionals who care for patients with cancer: a systematic review of training methods. Supportive Care in Cancer 13, 356-366.
27. Hack T.F., Degner L.F. & Parker P.A. (2005) The communication goals and needs of cancer patients: a review. Psycho-Oncology 14, 831-845. Discussion 846-837.
28. Halldorsdottir S. & Hamrin E. (1996) Experiencing existential changes: the lived experience of having cancer. Cancer Nursing 19, 29-36.
29. Harrison J.D., Solomon M.J., Young J.M., Meagher A., Hruby G., Salkeld G. & Clarke S. (2007) Surgical and oncology trials for rectal cancer: who will participate? Surgery 142, 94-101.
30. Huizinga G.A., Sleijfer D.T., van de Wiel H.B. & van der Graaf W.T. (1999) Decision-making process in patients before entering phase III cancer clinical trials: a pilot study. Cancer Nursing 22, 119-125.
31. Jefford M. & Moore R. (2008) Improvement of informed consent and the quality of consent documents. The Lancet Oncology 9, 485-493.
32. Klemp J.R., O'Dea A., Chamberlain C. & Fabian C.J. (2005) Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial. Familial Cancer 4, 279-284.
33. Kodish E.D., Pentz R.D., Noll R.B., Ruccione K., Buckley J. & Lange B.J. (1998) Informed consent in the Childrens Cancer Group: results of preliminary research. Cancer 82, 2467-2481.
34. Koyfman S.A., McCabe M.S., Emanuel E.J. & Grady C. (2009) A consent form template for phase I oncology trials. IRB 31, 1-8.
35. Mathews C., Restivo A., Raker C., Weitzen S. & Disilvestro P. (2009) Willingness of gynecologic cancer patients to participate in clinical trials. Gynecologic Oncology 112, 161-165.
36. Murthy V.H., Krumholz H.M. & Gross C.P. (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA: The Journal of the American Medical Association 291, 2720-2726.
37. National Cancer Institute (2012) Cancer - Changing the Conversation: Connecting the Nation's Cancer Community. National Cancer Institute, Bethesda, MD, USA.
38. Peppercorn J.M., Weeks J.C., Cook E.F. & Joffe S. (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363, 263-270.
39. Rasco D.W., Xie Y., Yan J., Sayne J.R., Skinner C.S., Dowell J.E. & Gerber D.E. (2009) The impact of consenter characteristics and experience on patient interest in clinical research. The Oncologist 14, 468-475.
40. Riechelmann R.P., Wang L., O'Carroll A. & Krzyzanowska M.K. (2007) Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. Journal of Clinical Oncology 25, 4642-4647.
41. Ruccione K.S., Hinds P.S., Wallace J.D. & Kelly K.P. (2005) Creating a novel structure for nursing research in a cooperative clinical trials group: the Children's Oncology Group experience. Seminars in Oncology Nursing 21, 79-88.
42. Sanatani M.S. & Vincent M.D. (2007) Balancing risk and benefit for first-line treatment of metastatic colorectal cancer: a graphic communication tool for patients and physicians. Supportive Cancer Therapy 4, 101-109.
43. Sankar P. (2004) Communication and miscommunication in informed consent to research. Medical Anthropology Quarterly 18, 429-446.
44. Sateren W.B., Trimble E.L., Abrams J., Brawley O., Breen N., Ford L., McCabe M., Kaplan R., Smith M., Ungerleider R., Christian M.C. (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. Journal of Clinical Oncology 20, 2109-2117.
45. Schroevers M.J., Kraaij V. & Garnefski N. (2011) Cancer patients' experience of positive and negative changes due to the illness: relationships with psychological well-being, coping, and goal reengagement. Psycho-Oncology 20, 165-172.
46. Selby P. (2011) The impact of the process of clinical research on health service outcomes. Annals of Oncology 22 (Suppl. 7), vii2-vii4.
47. Selby P. & Autier P. (2011) The impact of the process of clinical research on health service outcomes. Annals of Oncology 22 (Suppl. 7), vii5-vii9.
48. Stewart J.H., Bertoni A.G., Staten J.L., Levine E.A. & Gross C.P. (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Annals of Surgical Oncology 14, 3328-3334.
49. Thorne S., Reimer Kirkham S. & MacDonald-Emes J. (1997) Interpretive description: a non-categorical qualitative alternative for developing nursing knowledge. Research in Nursing & Health 20, 169-177.
50. Thorne S., Reimer Kirkham S. & O'Flynn-Magee K. (2004) The analytic challenge in interpretive description. International Journal of Qualitative Methods 3, 1-11. http://ejournals.library.ualberta.ca/index.php/IJQM/article/view/4481/3619.
51. Thorne S., Oliffe J.L. & Stajduhar K.I. (2013) Communicating shared decision-making: cancer patient perspectives. Patient Education and Counseling 90, 291-296.
52. Thorne S.E. (2008) Interpretive Description. Left Coast Press, Walnut Creek, CA, USA.
53. Townsley C.A., Chan K., Pond G., Marquez C., Siu L. & Straus S. (2006) Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 6, 34.
54. Weinfurt K.P., Depuy V., Castel L.D., Sulmasy D.P., Schulman K.A. & Meropol N.J. (2005) Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. Cancer 103, 140-147.
55. West J., Wright J., Tuffnell D., Jankowicz D. & West R. (2005) Do clinical trials improve quality of care? A comparison of clinical processes and outcomes in patients in a clinical trial and similar patients outside a trial where both groups are managed according to a strict protocol. Quality & Safety in Health Care 14, 175-178.
56. Yee K.W., Pater J.L., Pho L., Zee B. & Siu L.L. (2003) Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? Journal of Clinical Oncology 21, 1618-1623.
57. Zhang J., Zhang H., Yu C., Li J. & Jiang Y. (2011) The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials. Contemporary Clinical Trials 32, 649-653.